Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
Affiliation
Department of Medical Oncology ,The First Medical Centre ,Chinese People’s Liberation Army General Hospital ,Beijing ,China
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine ,Institute of Radiation Medicine ,Peking Union Medical College and Chinese Academy of Medical Sciences ,Tianjin ,China
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine ,Institute of Radiation Medicine ,Peking Union Medical College and Chinese Academy of Medical Sciences ,Tianjin ,China
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine ,Institute of Radiation Medicine ,Peking Union Medical College and Chinese Academy of Medical Sciences ,Tianjin ,China
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine ,Institute of Radiation Medicine ,Peking Union Medical College and Chinese Academy of Medical Sciences ,Tianjin ,China
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine ,Institute of Radiation Medicine ,Peking Union Medical College and Chinese Academy of Medical Sciences ,Tianjin ,China
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine ,Institute of Radiation Medicine ,Peking Union Medical College and Chinese Academy of Medical Sciences ,Tianjin ,China